1. Allan, P. W., Bennett, L.L., JB.: 6-Methylthioguanylic acid, a metabolite of 6-thioguanine. Biochem. Pharmacol. 20, 847–852 (1971).
2. Allan, P.W., Schnebli, H.P., Bennett, L.L., JR.: Conversion of 6-mercaptopurine and 6-mercaptopurine ribonucleoside to 6-methylmercaptopurine ribonucleotide in human epidermoid carcinoma No. 2 cells in culture. Biochim. biophys. Acta (Amst.) 114, 647–650 (1966).
3. Anonymous: Allopurinol and the control of hyperuricemia in neoplastic disease. Med. Let. Drugs Therap. 10, 103–104 (1968).
4. Aoki, Y., Moore, G. E.: Comparative sensitivity to various antimetabolites of several established cell lines derived from the buffy coat of normal humans and patients with neoplastic diseases. Cancer Res. 29, 1307–1312 (1969).
5. Ashton, H., Beveridge, G. W., Stevenson, C.J.: Therapeutics. XI. Immunosuppressive drugs. Brit. J. Derm. 83, 326–330 (1970).